A new drug summary about an investigational HIV drug called GSK3640254 is available on Clinical Info.

View as a webpage  /  Share May 27, 2021 Clinical Info Releases New Drug Summary on Investigational HIV Drug A new drug summary about an investigational HIV drug called GSK3640254 is available on Clinical Info. GSK3640254 is being studied to treat HIV infection and is currently in Phase IIb development. It is a maturation inhibitor and works during the last stage of the HIV life cycle to inhibit the formation of mature, infectious virus. Maturation inhibitors target HIV differently than currently approved HIV drugs and may potentially offer new treatment options for individuals who may have experienced resistance to other HIV medications.  For more information about GSK3640254, see the patient and health professional drug summaries. To learn more about investigational HIV medicines, check out the HIVinfo What is an Investigational HIV Drug? fact sheet. Stay Connected with HIVinfo:       SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

 

---

You are subscribed as myhcistech.healthnews360@blogger.com.  Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

This service is provided in collaboration with NIH's Office of AIDS Research and HHS Office of Infectious Disease and HIV/AIDS Policy/HIV.gov.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: HIVinfo · 8600 Rockville Pike · Bethesda, MD 20894 · 888-346-3656